A recent noninferiority randomized trial showed that in terms of clinical effectiveness imiquimod was superior and topical fluorouracil noninferior to methylaminolaevulinate photodynamic therapy ( MAL-PDT ) for treatment of superficial basal-cell carcinoma ( sBCC ) .